There is much to say about the contaminated blood scandal of the 1970s and ‘80s. It devastated the bleeding disorders…
After years on the track, gene therapy for haemophilia seems to have the home straights firmly in sight. Products for…
If you live with a bleeding disorder, self-advocacy isn’t just important – it’s vital. As a group of people who…
A recent paper in The Journal of Haemophilia Practice by Bhabani Sankar Dhal and colleagues describes the importance of regular…
Last week, Kate and I hopped over the pond to attend the Glanzmann’s Research Foundation’s (GRF) first ever educational conference…
Last year, the first gene therapy to treat severe haemophilia A was granted ‘conditional marketing authorisation’ in Europe (basically, fast-track…
The International Society for Thrombosis and Haemostasis (ISTH) is an organisation of clinicians and scientists sharing new discoveries, enhanced understanding…
In a recent paper in The Journal of Haemophilia Practice, Tyler Buckner and colleagues describe the development of ‘ATHN 7’.…
There is always a sense of anticipation among Haemnet’s publications team when we receive the annual report for The Journal…
For International Nurses Day 2023, I’m delighted that The Journal of Haemophilia Practice is publishing the first papers in our Living,…
People whose bleeding disorders are categorised as ‘mild’ (often defined as having between 5% to 40% of usual clotting levels)…
The theme of World Hemophilia Day this year is “Access for All: Prevention of bleeds as the global standard of care”.…